Birchview Capital’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Birchview Capital’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-40,000	Closed	-$215K	–	47
2016 Q2	$215K	Hold	40,000	–	–	0.16%	32
2016 Q1	$184K	Hold	40,000	–	–	0.13%	35
2015 Q4	$208K	Sell	40,000 -14,000	-26%	-$81.2K	0.12%	37
2015 Q3	$327K	Buy	54,000 +8,000	+17%	+$98K	0.21%	32
2015 Q2	$726K	Buy	46,000 +16,000	+53%	+$194K	0.38%	23
2015 Q1	$326K	Buy	+30,000	New	+$306K	0.17%	32

Other funds holding RPTP

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Birchview Capital's RPTP Position: Q3 2016 in Review

Birchview Capital sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 40,000 shares — an estimated $215K sold.

Birchview Capital first reported a position in RPTP in Q1 2015 and held it in 6 quarters. The position peaked at $726K in Q2 2015. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

Birchview Capital reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Birchview Capital sold 40,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $215K.
Birchview Capital first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q1 2015 and held it in 6 quarters.
Birchview Capital's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $726K in Q2 2015.
111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Birchview Capital's 13F filing for Q3 2016, filed 14 Nov 2016.